Abstract
Hypoglycemia is a common and feared complication of insulin therapy. As in type 1 and type 2 diabetes, people with cystic fibrosis related diabetes are also at risk for hypoglycemia related to insulin therapy. Spontaneous hypoglycemia is also common in patients with CF without diabetes, who are not on glucose lowering medications. Spontaneous hypoglycemia in CF may also occur during or after an oral glucose tolerance test. In this review, we will discuss the definition, epidemiology, pathophysiology and impact of hypoglycemia, with a focus on people with cystic fibrosis. We will also review strategies to manage and prevent hypoglycemia.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S19-S24 |
| Journal | Journal of Cystic Fibrosis |
| Volume | 18 |
| DOIs | |
| State | Published - Oct 2019 |
Bibliographical note
Publisher Copyright:© 2019 European Cystic Fibrosis Society
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- CFRD
- Cystic fibrosis
- Hypoglycemia
- Reactive hypoglycemia
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
Fingerprint
Dive into the research topics of 'Hypoglycemia in cystic fibrosis: Prevalence, impact and treatment'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS